U2Bio Market Cap

U2Bio has a market cap or net worth of 427.79 billion as of February 27, 2026. Its market cap has increased by 1,191.32% in one year.

Market Cap

427.79B

Enterprise Value

397.84B

Revenue

25.59B

Ranking

n/a

PE Ratio

n/a

Stock Price

26,850.00

Market Cap Chart

Since April 3, 2017, U2Bio's market cap has increased from 28.86B to 427.79B, an increase of 1,382.53%. That is a compound annual growth rate of 35.35%.

Market Cap History

Date	Market Cap	% Change
Feb 26, 2026	427.79B	705.73%
Dec 30, 2025	53.09B	76.50%
Dec 30, 2024	30.08B	-49.53%
Dec 28, 2023	59.60B	20.84%
Dec 29, 2022	49.32B	-12.03%
Dec 30, 2021	56.07B	276.76%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 3, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Humedix	439.12B
UTI Inc.	436.75B
Nepes	431.90B
CMES Inc.	431.45B
Devsisters corporation	425.43B
DIT Corp.	423.02B
POONGWON PRECISION CO.,Ltd.	420.62B
KOSES Co.,Ltd	419.24B

Market Cap Rankings